Abstract:Background As an adipocytokine, resistin has been proposed as a link between inflammation, metabolic disorder and atherosclerosis. The aim of the study is to evaluate whether serum resistin is associated with acute coronary syndrome (ACS) and major adverse cardiovascular events (MACEs) among postmenopausal women with ACS undergoing percutaneous coronary intervention (PCI). Methods A total of 106 consecutive postmenopausal women who underwent coronary angiography for evaluation of suspected myocardial ischemia were enrolled. Pre-procedure serum resistin, inflammatory and metabolic biomarkers were measured. All participants were followed for seven years for MACEs, including cardiovascular death, recurrent nonfatal myocardial infarction, and re-PCI. Results Patients with ACS (n=69) had significantly higher resistin levels than those without coronary artery disease (CAD) (n=37) (4.61 (1.79-10.80) ng/ml vs. 2.36 (0.85-4.15) ng/ml, P=0.002). Correlation analysis revealed positive correlations between resistin levels and inflammatory and metabolic factors (P <0.05). A follow-up of a mean of 83.4 months showed that patients with ACS suffered more MACEs than those without (13.0% vs. 2.7%, P=0.05). Adjusted for cardiovascular risks, inflammatory and metabolic factors, multiple Logistic regression analysis indicated that an elevated resistin level was an independent predictor of ACS onset (OR=1.139, 95% CI 1.024-1.268, P=0.017) and of MACEs after PCI (OR=1.099, 95% CI 1.015-1.189, P=0.019). To clarify the association between resistin levels and MACEs, ACS patients were divided into two subgroups on the basis of resistin levels. Compared with the low resistin subgroup (≥4.35 ng/ml, n=32), patients in the high resistin subgroup (>4.35 ng/ml, n=37) were more prone to suffer MACEs (21.6% vs. 3.1%, P=0.015). Kaplan-Meier analysis showed a significantly lower event-free survival rate in ACS patients with high resistin levels than in the low resistin subgroup (78.4% vs. 96.9%, Log rank 5.594, P=0.018). Conclusion An elevated serum resistin level is associated with ACS and cardiovascular events and acts as a predictor in progression of ACS in postmenopausal women.

Study on the Relationship between Serum Resistin and Acute Coronary Syndrome and Stable Angina Pectoris

Relationship Between Resistin Level in Serum and Acute Coronary Syndrome or Stable Angina Pectoris

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Study of Serum Resistin Level in Patients with Acute Coronary Syndrome

Elevated Levels of Serum Resistin in Type 2 Diabetic Patients and Those with Coronary Artery Diseases

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

The Significance of Serum IgE Levels for Different Types of Coronary Atherosclerotic Heart Diseases

Study in the relationship between severity of coronary artery disease and high sensitive-C reaction protein as well as insulin resistance

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Relationship Between Autoantibodies Against Oxidized Low-Density Lipoprotein and High-Sensitivity C-reactive Protein in Patients with Coronary Artery Disease

To Explore the Relationship between Clinical Serum Markers and Intracoronary in-stent Restenosis

Relationship Between the High-Sensitivity C-reactive Protein,cardiac Troponin I and Severity of Coronary Lesion

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Increased serum resistin level is associated with coronary heart disease

Relationship between resistin and acute myocardial infarction in postmenopausal women

Plasma Resistin Associated With Myocardium Injury In Patients With Acute Coronary Syndrome

Association Between Serum Resistin Level and Cardiovascular Events in Postmenopausal Women with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Chemokine CXCL16 Expression in Serum of Patients with Coronary Artery Disease

Detection and Significance of Serum IL-18 in Patients with Acute Coronary Syndromes